OncoC4
1 known investors
Clinical-stage immuno-oncology company developing a best-in-class CTLA-4 antibody and first-in-class CD24 antibody.
1 known investors
Clinical-stage immuno-oncology company developing a best-in-class CTLA-4 antibody and first-in-class CD24 antibody.